Krystal Biotech 2024年第四季度GAAP每股收益$1.52, 超过预期$1.16，销售额$91.14M, 超过预期$90.49M

财报速递2025-02-19
Krystal Biotech（纳斯达克股票代码：KRYS）报告季度每股收益为$1.52，这超过了分析师普遍预计的$1.16，超出31.03%。 这是与去年同期每股收益$0.30相比增长了406.67%。该公司报告季度销售额为$91.14百万，超过了分析师普遍预计的$90.49百万，超出0.72%。这与去年同期销售额$42.14百万相比增长了116.26%。

以上内容来自Benzinga Earnings专栏，原文如下：

Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $1.16 by 31.03 percent. This is a 406.67 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $91.14 million which beat the analyst consensus estimate of $90.49 million by 0.72 percent. This is a 116.26 percent increase over sales of $42.14 million the same period last year.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法